Clinical trial

PK Study of PT003 and PT001 in Japanese Healthy Subjects

NCT02196714

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE1

Study timeline

Study start (unknown)2014-07-01Date precision: month

Registry last updated2017-04-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Interventions

Glycopyrronium and Formoterol Fumarate (GFF) Dose 1DRUG

Glycopyrronium and Formoterol Fumarate (GFF) Dose 2DRUG

Glycopyrronium (GP) Dose 1DRUG

Glycopyrronium (GP) Dose 2DRUG

Sponsors & collaborators

Pearl Therapeutics, Inc.lead sponsor

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02196714 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.